90 likes | 102 Views
1/15. 1/20. 1/13. 9/18. 12/23. 12/4. 11/6. 9/11. 10/30. 10/9. 10/16. 11/13. 1/29. 10/16. 9/11. Insp Test/ Comment. September 11, 2009. HITSP 2009 TC Timeline Overview
E N D
1/15 1/20 1/13 9/18 12/23 12/4 11/6 9/11 10/30 10/9 10/16 11/13 1/29 10/16 9/11 Insp Test/ Comment September 11, 2009 HITSP 2009 TC Timeline Overview Note: Quality Measures, Consumer Preferences, Clinical Research, Common Data Transport may deviate from the timeline below, as their timelines are further established they will be included as separate line items 11/2 HITSP TCL DC Area 8/24 HITSP TCL, Chicago 12/1 HITSP Board 8/25-8/27 TC F2F, Chicago 1/11-1/15 Connectathon 9/8 HITSP Board 11/3 – 11/5 TC F2F DC Area DEC AUG SEPT OCT NOV JAN CAP Req & Des Webinar (9/29-10/1) 1/20 HITSP Panel 9/15 HITSP Panel 12/15 HITSP Panel 2009 Work Items: Wave 1 R&D (Requirements and Design) Development 3 weeks (longer duration due to holidays) Comment & Resolution 1 week (assumption is F2F Pub.) Panel Review Comment Draft IS Dev 1 week 6.5 Weeks 6 Weeks 1 Week 4 Weeks 2009 Work Items: Wave 2 R&D (Requirements and Design) Development 2 weeks Comment Draft IS Dev 1 week 4 Weeks 15 Weeks WE ARE HERE Short Term Items August & September Generalize/Conform SPI SCs/Capabilities, TC Plans for Transition, Gap Resolution for Meaningful Use, Finalize Templates Holiday Full TC Meetings Ongoing Efforts Testing Support, Tooling Efforts, Foundations, NHIN Support, ARRA Gaps & Feedback from ONC IRT Content, Editorial and Quality Review Connectathon Panel Approval
10/1 9/15 Timeline for Capabilities Generalization 11/2 HITSP TCL DC Area 8/24 HITSP TCL, Chicago 12/1 HITSP Board 8/25-8/27 TC F2F, Chicago 1/11-1/15 Connectathon 9/8 HITSP Board 11/3 – 11/5 TC F2F DC Area DEC AUG SEPT OCT NOV JAN 1/20 HITSP Panel 9/15 HITSP Panel 12/15 HITSP Panel Capabilities Team Quality Development of Generalized Capabilities Documents TC Comment 4 Weeks WE ARE HERE Holiday Full TC Meetings IRT Content, Editorial and Quality Review Connectathon Panel Approval
Activities During Wave 1 Quality Measures (Pop) Common Data Transport** (SPI) Newborn Screening (Pop) Consumer Preferences** (SPI/Cons) Clinical Research (Pop) General Lab Orders (Prov) Medication Gaps (Cons) Prior-Authorization (Admin) Rationale ONC high-priority items For the purpose of proper resource utilization, the Program Management Team selected additional work items to include in Wave 1, supplemental to ONC identified priorities so that each TC would have a work item in Wave 1. CMHR/Data Architecture was not included as they have other prioritized items to complete 2009 Work Items Split Up by Waves Activities During Wave 2(Nominal Risk) Clinical Encounter Notes (CMHR) Common Device Connectivity (Cons) Long Term Care (Prov) Maternal and Child Health (Pop) Medical Home: Co-Morbidity & Registries (Cons) Order Sets (Prov) Scheduling (Admin) Wave 3(Greater Risk) Consumer Adverse Event Reporting (Pop) ONC Priorities ** = May be on different schedule – beginning in August
Capacity Risk • Some factors lead to capacity risks for expected delivery on the originally-assigned work • Time for context switching between tiger teams and technical committees (both on front end and back end of 90-day effort) • Lingering work items resulting from ARRA focus, and accommodation of new HITSP artifacts that support ARRA (e.g. – capabilities, service collaborations) • Requirements that are yet-to-be determined (e.g. – consumer preferences) • Requirements finalized during 90-day ARRA effort that need further assessment (e.g. – Common Data Transport) • Original risk of gap/extension “sizing” outstripping capacity
Items to Review Requirements & Design Webinars